November 13, 2020
“Sequans Communications (SQNS)… Sequans holds a unanimous Strong Buy rating from the analyst consensus, based on 4 Buy reviews given in the last two months. Furthermore, the average price target suggests it will more than double, growing by 148% from… Continue Reading…
October 20, 2020
“Neos Therapeutics (NEOS)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, NEOS has a Strong Buy consensus rating. At $8.33, the average price target… Continue Reading…
October 14, 2020
“Silicon Motion (SIMO)… Turning to the rest of the Street, the bulls have it on this one. With 4 Buys and a lone Hold, the word on the Street is that SIMO is a Strong Buy. At $49.60, the average… Continue Reading…
October 9, 2020
“The market has seen record lows followed by record highs over the course of this year, and investors who have been sitting on the sidelines to avoid the madness might believe that they’ve missed an opportunity to jump in at… Continue Reading…
October 7, 2020
“Northern Oil and Gas (NOG)… Wall Street agrees with Hughes on the potential here; the analyst consensus rating of Strong Buy comes from a unanimous 5 positive reviews. Shares are priced at $5.30 and have an average price target of $14,… Continue Reading…
October 1, 2020
“PDC Energy (PDCE)… Are other analysts in agreement? They are. Only Buy ratings, 11, in fact, have been issued in the last three months. Therefore, the verdict is unanimous: PDCE is a Strong Buy. Given the $21.50 average price target,… Continue Reading…
September 17, 2020
“Akero Therapeutics (AKRO)… Are other analysts in agreement? They are. Only Buy ratings, 6, in fact, have been issued in the last three months. Therefore, the message is clear: AKRO is a Strong Buy. Given the $58.50 average price target,… Continue Reading…
September 2, 2020
“Baudax Bio (BXRX) First up we have Baudax Bio, which is a pharmaceutical company focused on developing and commercializing innovative products for acute care settings. With shares changing hands for $2.80, Oppenheimer believes that the share price presents an attractive… Continue Reading…
September 5, 2019
““We were looking for a correction in August, but we believe the market will rally into the end of the year,” Matejka said in an interview. “The key call is that the U.S. is not headed for a recession. The… Continue Reading…
Recent Comments